Modeling the Efficacy of Natalizumab in Multiple Sclerosis...

  • Main
  • 2020 / 09
  • Modeling the Efficacy of Natalizumab in Multiple Sclerosis...

Modeling the Efficacy of Natalizumab in Multiple Sclerosis Patients Who Switch From Every‐4‐Week Dosing to Extended‐Interval Dosing

Chang, Ih, Muralidharan, Kumar Kandadi, Campbell, Nolan, Ho, Pei‐Ran
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
The Journal of Clinical Pharmacology
DOI:
10.1002/jcph.1737
Date:
September, 2020
File:
PDF, 1.14 MB
2020
Conversion to is in progress
Conversion to is failed